Decision aid for prostate cancer screening in Brazil

Authors

DOI:

https://doi.org/10.11606/s1518-8787.2022056003467

Keywords:

Prostatic Neoplasms, prevention & control, Mass Screening, Clinical Decision-Making, Use of Scientific Information for Health Decision Making, Physician-Patient Relations

Abstract

OBJECTIVE To present the development and validation processes of a decision aid for prostate cancer screening in Brazil. METHODS Study with qualitative-participatory design for the elaboration of a decision aid for prostate cancer screening, with the participation of a group of men and physicians inserted in primary health care in 11 Brazilian states. Evidence synthesis, field testing, and use in clinical scenarios were performed to adapt the content, format, language, and applicability towards the needs of the target audience in the years 2018 and 2019. The versions were subsequently evaluated by the participants and modified based on the data obtained. RESULTS We elaborated an unprecedented tool in Brazil, with information about the tests used in the screening, comparison of their possible benefits and harms and a numerical infographic with the consequences of this practice. We verified the decision aid usability to assist in the communication between the doctor and the man in the context of primary health care, besides identifying the need for greater discussion about sharing decisions in clinical scenarios. CONCLUSION The tool was easy to use, objective, and has little interference in consultation time. It is a technical-scientific material, produced by research, with the participation of its main target audience and which is available free of charge for use in Brazilian clinical scenarios.

References

Lowenstein LM, Basourakos SP, Williams MD, Troncoso P, Gregg JR, Thompson TC, et al. Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned. Nat Rev Clin Oncol. 2019;16(3):168-84 https://doi.org/10.1038/s41571-018-0116-x

Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, Melnikow J. Prostate-specific antigen–based screening for prostate cancer: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;319(18):1914-31. https://doi.org/10.1001/jama.2018.3712

Modesto AAD, Lima RLB, D’Angelis AC, Augusto DK. Um novembro não tão azul: debatendo rastreamento de câncer de próstata e saúde do homem. Interface. 2018;22(64):251-62. https://doi.org/10.1590/1807-57622016.0288

Ministério da Saúde (BR), Secretaria de Atenção à Saúde, Coordenação Nacional de Saúde dos Homens, Coordenação de Saúde da Pessoa Idosa; Instituto Nacional do Câncer. Nota Técnica Conjunta n° 001/2015. Posicionamento do Ministério da Saúde acerca da integralidade da saúde dos homens no contexto do Novembro Azul. Brasília, DF; 2015 [citado 3 mar 2019]. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/nota-tecnica-saude-do-homem-ms.pdf

Instituto Nacional de Câncer. Rastreamento do Câncer de Próstata. Rio de Janeiro: INCA; 2013 [citado 13 mar 2019]. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/rastreamento-prostata-2013.pdf

Coylewright M, Keevil JG, Xu K, Dodge SE, Frosch D, Field ME. Pragmatic study of clinician use of a personalized patient decision aid integrated into the electronic health record: an 8-year experience. Telemed J E Health. 2020;26(5):597-602. https://doi.org/10.1089/tmj.2019.0112

Stacey D, Légaré F, Lewis K, Barry MJ, Bennett CL, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017;(4):CD001431. https://doi.org/doi/10.1002/14651858.CD001431.pub5/full

Riikonen JM, Guyatt GH, Kilpeläinen TP, Craigie S, Agarwal A, Agoritsas T, et al. Decision aids for prostate cancer screening choice: a systematic review and meta-analysis. JAMA Intern Med. 2019;179(8):1072-82. https://doi.org/10.1001/jamainternmed.2019.0763

Ministério da Saúde (BR). Portaria de Consolidação Nº 2. Consolidação das normas sobre as políticas de saúde do Sistema Único de Saúde. Anexo IX Política Nacional para Prevenção e Controle do Câncer (PNPCC). Art 3º. Brasília, DF; 2017 [citado 11 dez 2018]. Disponível em: https://bvsms.saude.gov.br/bvs/saudelegis/gm/2017/MatrizesConsolidacao/Matriz-2-Politicas.html

Sepucha KR, Abhyankar P, Hoffman AS, Bekker HL, LeBlanc A, Levin CA, et al. Standards for UNiversal reporting of patient decision aid evaluation studies: the development of SUNDAE Checklist. BMJ Qual Saf. 2018;27(5):380-8. https://doi.org/10.1136/bmjqs-2017-006986

Abreu MM, Gafni A, Ferraz MB. The use of a decision board to elicit Brazilian patients’ and physicians’ preferences for treatment: the case of lupus nephritis. Value Health. 2011;14(5 Suppl):S141-6. https://doi.org/10.1016/j.jval.2011.05.015

Ferraz MB, Ciconelli RM, Vilar MJ. Patient’s preference regarding the option of performing unselective liver biopsy following methotrexate treatment in rheumatoid arthritis. Clin Exp Rheumatol. 1994;12(6):621-5.

Wallerstein NB, Duran B. Using community-based participatory research to address health disparities. Health Promot Pract. 2006;7(3):312-23. https://doi.org/10.1177/1524839906289376

Parker M, Wallerstein N, Duran B, Magarati M, Burgess E, Sanchez-Youngman S, et al. Engage for equity: development of community-based participatory research tools. Health Educ Behav. 2020;47(3):359-71. https://doi.org/10.1177/1090198120921188

Canadian Task Force on Preventive Health Care. Ottawa (CA): CTFPHC; 2014 [citado 31 dez 2019]. Disponível em: https://canadiantaskforce.ca/

US Preventive Services Task Force. Final Recommendation Statement: Prostate Cancer: screening. Rockville, MD: USPSTF; 2018 [citado 2 dez 2019]. Disponível em: https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/prostate-cancer-screening1

Moyer VA; U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(2):120-34. https://doi.org/10.7326/0003-4819-157-2-201207170-00459

Schröder FH, Hugosson J, Roobol MJ, Tammela TLJ, Zappa M, Nelen V, et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet. 2014;384(9959):2027-35. https://doi.org/10.1016/S0140-6736(14)60525-0

Ministério da Saúde (BR), Secretaria de Atenção à Saúde. Portaria Nº 498, de 11 de maio de 2016. Aprova as Diretrizes Diagnósticas e Terapêuticas do Adenocarcinoma de Próstata. Brasília, DF; 2016 [citado 23 dez 2020]. Disponível em: http://conitec.gov.br/images/Protocolos/DDT/DDT_Adenocarcinoma_Prostata.pdf

Ottawa Hospital. A to Z Inventory of Patient Decision Aids. Ottawa (CA): Hospital Research Institute; 2019 [citado 23 dez 2020]. Disponível em: https://decisionaid.ohri.ca/azinvent.php

Santos ROM, Romano VF, Engstrom EM. Vínculo longitudinal na Saúde da Família: construção fundamentada no modelo de atenção, práticas interpessoais e organização dos serviços. Physis. 2018;28(2):e280206. https://doi.org/10.1590/S0103-73312018280206

Pieterse AH, Stiggelbout AM, Montori VM. Shared decision making and the importance of time. JAMA. 2019;322(1):25-6. https://doi.org/10.1001/jama.2019.3785

Hargraves IG, Montori VM, Brito JP, Kunneman M, Shaw K, LaVecchia C, et al. Purposeful SDM: a problem-based approach to caring for patients with shared decision making. Patient Educ Couns. 2019;102(10):1786-92. https://doi.org/10.1016/j.pec.2019.07.020

Goldwag J, Marsicovetere P, Scalia P, Johnson HA, Durand MA, Elwyn G, et al. The impact of decision aids in patients with colorectal cancer: a systematic review. BMJ Open. 2019;9(9):e028379. https://doi.org/10.1136/bmjopen-2018-028379

Nunes FDBRS, Almeida ADL. Informação médica e consentimento de pessoas com câncer. Rev Bioética. 2018;26(1):119-26. https://doi.org/10.1590/1983-80422018261233

Stephan LS, Almeida ED, Guimarães RB, Ley AG, Mathias RG, Assis MV, et al. Anticoagulação oral na fibrilação atrial: desenvolvimento e avaliação de um aplicativo de saúde móvel para suporte à decisão compartilhada. Arq Bras Cardiol. 2018;110(1):7-15. https://doi.org/10.5935/abc.20170181

Abreu MM, Battisti R, Martins RS, Baumgratz TD, Cuziol M. Shared decision making in Brazil: history and current discussion. Z Evid Fortbild Qual Gesundhwes. 2011;105(4):240-4. https://doi.org/10.1016/j.zefq.2011.04.009

Abreu MM, Kowalski SC, Ciconelli RM, Ferraz MB. Apoios de decisão: instrumento de auxílio à medicina baseada em preferências. Uma revisão conceitual. Rev Bras Reumatol. 2006;46(4):266-72. https://doi.org/10.1590/S0482-50042006000400006

Published

2022-04-08

Issue

Section

Original Articles

How to Cite

Decision aid for prostate cancer screening in Brazil. (2022). Revista De Saúde Pública, 56, 19. https://doi.org/10.11606/s1518-8787.2022056003467